S. Plott

Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.

C. Nemeroff, M. Owens, W. N. Morgan, 1997, The Journal of pharmacology and experimental therapeutics.

Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine

M. Thase, C. Nemeroff, M. Owens, 2008, Neuropsychopharmacology.

Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

C. Kilts, M. Owens, S. Plott, 2015, Bioorganic & medicinal chemistry.

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity

C. Nemeroff, S. Vaishnavi, Srinivas G. Rao, 2003, Biological Psychiatry.

Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.

J. Votaw, M. Owens, S. Plott, 2010, Journal of medicinal chemistry.

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity

C. Nemeroff, S. Vaishnavi, Srinivas G. Rao, 2004, Biological Psychiatry.

Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

C. Kilts, M. Owens, S. Plott, 2015, Bioorganic & medicinal chemistry.